1. Home
  2. NOTV vs XOS Comparison

NOTV vs XOS Comparison

Compare NOTV & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • XOS
  • Stock Information
  • Founded
  • NOTV 1974
  • XOS 2016
  • Country
  • NOTV United States
  • XOS United States
  • Employees
  • NOTV N/A
  • XOS N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • XOS Construction/Ag Equipment/Trucks
  • Sector
  • NOTV Health Care
  • XOS Consumer Discretionary
  • Exchange
  • NOTV Nasdaq
  • XOS Nasdaq
  • Market Cap
  • NOTV 126.3M
  • XOS 28.5M
  • IPO Year
  • NOTV 1997
  • XOS N/A
  • Fundamental
  • Price
  • NOTV $4.22
  • XOS $3.27
  • Analyst Decision
  • NOTV Strong Buy
  • XOS Buy
  • Analyst Count
  • NOTV 3
  • XOS 5
  • Target Price
  • NOTV $5.92
  • XOS $10.00
  • AVG Volume (30 Days)
  • NOTV 1.5M
  • XOS 28.8K
  • Earning Date
  • NOTV 02-05-2025
  • XOS 11-13-2024
  • Dividend Yield
  • NOTV N/A
  • XOS N/A
  • EPS Growth
  • NOTV N/A
  • XOS N/A
  • EPS
  • NOTV N/A
  • XOS N/A
  • Revenue
  • NOTV $490,739,000.00
  • XOS $62,863,000.00
  • Revenue This Year
  • NOTV $7.14
  • XOS $41.28
  • Revenue Next Year
  • NOTV $5.73
  • XOS $64.53
  • P/E Ratio
  • NOTV N/A
  • XOS N/A
  • Revenue Growth
  • NOTV N/A
  • XOS 81.07
  • 52 Week Low
  • NOTV $1.23
  • XOS $2.92
  • 52 Week High
  • NOTV $11.42
  • XOS $14.86
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 48.58
  • XOS 40.97
  • Support Level
  • NOTV $4.17
  • XOS $3.11
  • Resistance Level
  • NOTV $5.67
  • XOS $3.65
  • Average True Range (ATR)
  • NOTV 0.55
  • XOS 0.29
  • MACD
  • NOTV -0.11
  • XOS 0.04
  • Stochastic Oscillator
  • NOTV 22.87
  • XOS 25.26

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About XOS Xos Inc.

Xos Inc is an electric mobility company. It designs and develops fully electric battery mobility systems specifically for commercial fleets. The company's primary focus is on medium- and heavy-duty commercial vehicles that travel on last mile routes. The company leverages its proprietary technologies to provide commercial fleets zero emission vehicles that are easier to maintain and more cost-efficient on a total cost of ownership basis than internal combustion engine and commercial EV counterparts.

Share on Social Networks: